MESO Q1 2021 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena

MESOMesoblast Limited

$2B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-92.4% YoY

Gross Profit

-$27M-2100.6% margin

Operating Income

-$36M-2758.7% margin

Net Income

-$25M-1904.1% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

+86.3%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$713M

Total Liabilities

$174M

Stockholders' Equity

$539M

Cash & Equivalents

$108M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$17M	-92.4%
Gross Profit	-$27M	$14M	-291.0%
Operating Income	-$36M	-$4M	-915.4%
Net Income	-$25M	-$5M	-347.6%